FDA Approves Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) Tablets For The Treatment Of HIV Infection

US FDA gave green signal to Symfi Tablets For The Treatment Of HIV Infection

Mylan Pharmaceutical Inc.receives FDA approval for Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets for the treatment of HIV infection.

Company: Mylan Pharmaceutical Inc.

Brand Name: Symfi

Dosage Form: Capsule

Generic Name: efavirenz, lamivudine and tenofovir disoproxil fumarate

Dosage Form: Tablets

Treatment For: HIV Infection

 

 

General information about Symfi

Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) is a three-drug combination of a non-nucleoside reverse transcriptase inhibitor (efavirenz), and two nucleo(t)side reverse transcriptase inhibitors (lamivudine and tenofovir disoproxil fumarate) indicated as a complete regimen for the treatment of human immunodeficiency virus type 1(HIV) infection.

 

 

Our App

Connect with us

Oddway on facebook Oddway on pinterest Oddway on VK Oddway on LinkedIn Oddway on Twitter

Contact Us

  • icon
    Address : 4216/20, Ground Floor, 1 Ansari Road, Daryaganj,
               New Delhi - 110002 (India)
  • icon
    Phone : +91-11-43526658
    Mobile : +91-9873336444
  • icon
    WhatsApp : +91-9873336444
    Viber          : +91-9873336444

Oddway International is a Pharmaceutical Exporter & Supplier of Generic Medicine and Online Pharmacy Distributor in India...Read More

Top